{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T22:28:55Z","timestamp":1795127335622,"version":"4.10.3"},"reference-count":178,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1097\/aog.0000000000003072","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T02:15:39Z","timestamp":1548382539000},"page":"e128-e150","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":141,"title":["ACOG Practice Bulletin No. 206: Use of Hormonal Contraception in Women With Coexisting Medical Conditions"],"prefix":"10.1097","volume":"133","member":"276","reference":[{"issue":"RR-3","key":"R1-20230711","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R2-20230711","first-page":"e89","article-title":"Gynecologic care for women and adolescents with human immunodeficiency virus. Practice Bulletin No. 167. American College of Obstetricians and Gynecologists","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000001047","article-title":"Emergency contraception. Practice Bulletin No. 152. American College of Obstetricians and Gynecologists","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/01.AOG.0000450758.95422.c8","article-title":"Depot medroxyprogesterone acetate and bone effects. Committee Opinion No. 602. American College of Obstetricians and Gynecologists","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/AOG.0000000000001134","article-title":"Contraceptive use among women with medical conditions in a nationwide privately insured population","volume":"126","author":"Champaloux","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/AOG.0000000000002114","article-title":"Pregnancy-related mortality in the United States, 2011\u20132013","volume":"130","author":"Creanga","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.fertnstert.2012.11.037","article-title":"Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach","volume":"99","author":"Thoma","year":"2013","journal-title":"Fertil Steril"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/humupd\/dmt028","article-title":"Venous thromboembolism in women: a specific reproductive health risk. ESHRE Capri Workshop Group","volume":"19","year":"2013","journal-title":"Hum Reprod Update"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(03)14111-6","article-title":"Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study","volume":"362","author":"Baglin","year":"2003","journal-title":"Lancet"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1160\/TH03-03-0152","article-title":"Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures","volume":"90","author":"White","year":"2003","journal-title":"Thromb Haemost"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/bmj.302.6771.269","article-title":"Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgery","volume":"302","author":"Robinson","year":"1991","journal-title":"BMJ"},{"key":"R14-20230711","first-page":"429","article-title":"Prevention of deep vein thrombosis and pulmonary embolism. ACOG Practice Bulletin No. 84. American College of Obstetricians and Gynecologists [published erratum appears in Obstet Gynecol 2016;127:166]","volume":"110","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/AOG.0b013e31823d389e","article-title":"Prevention of venous thromboembolic events after gynecologic surgery [published erratum appears in Obstet Gynecol 2012;119:872","volume":"119","author":"Clarke-Pearson","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.hoc.2010.05.008","article-title":"Prevention and treatment of hormone-associated venous thromboembolism: a patient management approach","volume":"24","author":"Ueng","year":"2010","journal-title":"Hematol Oncol Clin North Am"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [published erratum appears in Chest 2012;141:1369]","volume":"141","author":"Gould","year":"2012","journal-title":"Chest"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive","volume":"72","author":"van den Heuvel","year":"2005","journal-title":"Contraception"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/0091270006297919","article-title":"Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive","volume":"47","author":"Devineni","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2009.07.004","article-title":"Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism","volume":"81","author":"Jick","year":"2010","journal-title":"Contraception"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/AOG.0b013e31825194ca","article-title":"Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective","volume":"119","author":"Raymond","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.contraception.2016.10.005","article-title":"Nonoral combined hormonal contraceptives and thromboembolism: a systematic review","volume":"95","author":"Tepper","year":"2017","journal-title":"Contraception"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115799","article-title":"Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease","volume":"133","author":"Gerstman","year":"1991","journal-title":"Am J Epidemiol"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N Engl J Med"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.contraception.2012.12.011","article-title":"Ethinyl estradiol and 17beta-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment","volume":"87","author":"Stanczyk","year":"2013","journal-title":"Contraception"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2016.06.010","article-title":"Impact of estrogen type on cardiovascular safety of combined oral contraceptives","volume":"94","author":"Dinger","year":"2016","journal-title":"Contraception"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1056\/NEJMe1204769","article-title":"Hormonal contraceptives and arterial thrombosis\u2014not risk-free but safe enough","volume":"366","author":"Petitti","year":"2012","journal-title":"N Engl J Med"},{"key":"R29-20230711","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.AOG.0000279448.62221.a8","article-title":"Risk of thromboembolism in women taking ethinylestradiol\/drospirenone and other oral contraceptives","volume":"110","author":"Seeger","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R30-20230711","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/AOG.0b013e3182a5ec6b","article-title":"Cardiovascular risk associated with the use of an etonogestrel-containing vaginal ring","volume":"122","author":"Dinger","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R31-20230711","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.contraception.2014.01.023","article-title":"Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives","volume":"89","author":"Dinger","year":"2014","journal-title":"Contraception"},{"key":"R32-20230711","first-page":"268.e5","article-title":"No. 329-Canadian Contraception Consensus Part 4 of 4 chapter 9: combined hormonal contraception","volume":"39","author":"Black","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"R34-20230711","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"key":"R35-20230711","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/00016340902730375","article-title":"Limited knowledge on progestogen-only contraception and risk of venous thromboembolism","volume":"88","author":"Bergendal","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R36-20230711","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/AOG.0000000000000411","article-title":"Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes [published erratum appears in Obstet Gynecol 2015;125:495]","volume":"124","author":"Bergendal","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R37-20230711","doi-asserted-by":"crossref","first-page":"e4944","DOI":"10.1136\/bmj.e4944","article-title":"Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis","volume":"345","author":"Mantha","year":"2012","journal-title":"BMJ"},{"key":"R38-20230711","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0010-7824(98)00041-9","article-title":"Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"57","year":"1998","journal-title":"Contraception"},{"key":"R39-20230711","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device","volume":"30","author":"van Hylckama Vlieg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R40-20230711","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0010-7824(93)90090-T","article-title":"A multicentre comparative study of serum lipids and apolipoproteins in long-term users of DMPA and a control group of IUD users. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research, Development and Research Training in Human Reproduction","volume":"47","author":"Kongsayreepong","year":"1993","journal-title":"Contraception"},{"key":"R41-20230711","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/AOG.0b013e3181b76bea","article-title":"Effect of injectable and oral contraceptives on serum lipids","volume":"114","author":"Berenson","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R42-20230711","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.160.1.49","article-title":"Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects","volume":"160","author":"Bloemenkamp","year":"2000","journal-title":"Arch Intern Med"},{"key":"R43-20230711","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.contraception.2005.08.011","article-title":"Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review","volume":"73","author":"Mohllajee","year":"2006","journal-title":"Contraception"},{"key":"R44-20230711","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archinte.167.3.282","article-title":"Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study","volume":"167","author":"van Vlijmen","year":"2007","journal-title":"Arch Intern Med"},{"key":"R45-20230711","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"R46-20230711","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/13625180008500383","article-title":"Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?","volume":"5","author":"Spannagl","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R47-20230711","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/bmj.313.7065.1127","article-title":"Factor V Leiden: should we screen oral contraceptive users and pregnant women?","volume":"313","author":"Vandenbroucke","year":"1996","journal-title":"BMJ"},{"issue":"suppl 1","key":"R48-20230711","first-page":"170","article-title":"Thrombophilic mechanisms of OCs","author":"Comp","year":"1997","journal-title":"Int J Fertil Womens Med"},{"key":"R49-20230711","doi-asserted-by":"crossref","first-page":"895","DOI":"10.7326\/0003-4819-127-10-199711150-00007","article-title":"Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective","volume":"127","author":"Price","year":"1997","journal-title":"Ann Intern Med"},{"key":"R50-20230711","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1055\/s-0037-1615380","article-title":"Hyperhomocysteinemia and venous thrombosis: a meta-analysis","volume":"80","author":"den Heijer","year":"1998","journal-title":"Thromb Haemost"},{"key":"R51-20230711","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000083825","article-title":"Homocysteine, vitamin B6 and the risk of recurrent venous thromboembolism","volume":"33","author":"Eichinger","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"R52-20230711","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1538-7836.2005.01141.x","article-title":"Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies","volume":"3","author":"Den Heijer","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R53-20230711","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00001721-200207000-00007","article-title":"Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease","volume":"13","author":"Domagala","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R54-20230711","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. European Working Party on Systemic Lupus Erythematosus","volume":"82","author":"Cervera","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"R55-20230711","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0961203307083316","article-title":"Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus","volume":"16","author":"Martinez-Berriotxoa","year":"2007","journal-title":"Lupus"},{"key":"R56-20230711","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/art.24232","article-title":"Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies","volume":"61","author":"Tektonidou","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R57-20230711","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"R59-20230711","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10067-007-0721-z","article-title":"Lupus nephritis and Raynaud's phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies","volume":"27","author":"Choojitarom","year":"2008","journal-title":"Clin Rheumatol"},{"key":"R60-20230711","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/096120339700600510","article-title":"Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus\u2014a meta-analysis","volume":"6","author":"Wahl","year":"1997","journal-title":"Lupus"},{"key":"R61-20230711","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/AOG.0b013e3181ae9c64","article-title":"Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review","volume":"114","author":"Culwell","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R62-20230711","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1056\/NEJMoa050817","article-title":"A trial of contraceptive methods in women with systemic lupus erythematosus","volume":"353","author":"Sanchez-Guerrero","year":"2005","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"R63-20230711","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/01.aids.0000363778.58203.b6","article-title":"Safety of hormonal and intrauterine methods of contraception for women with HIV\/AIDS: a systematic review","volume":"23","author":"Curtis","year":"2009","journal-title":"AIDS"},{"key":"R64-20230711","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.contraception.2010.02.007","article-title":"Contraceptive use among solid organ transplant patients: a systematic review","volume":"82","author":"Paulen","year":"2010","journal-title":"Contraception"},{"key":"R65-20230711","doi-asserted-by":"crossref","first-page":"126.e1","DOI":"10.1016\/j.ajog.2010.09.002","article-title":"The levonorgestrel-releasing intrauterine system in human immunodeficiency virus-infected women: a 5-year follow-up study","volume":"204","author":"Heikinheimo","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R66-20230711","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.contraception.2011.12.008","article-title":"Use of the levonorgestrel-releasing intrauterine system in renal transplant recipients: a retrospective case review","volume":"86","author":"Ramhendar","year":"2012","journal-title":"Contraception"},{"key":"R67-20230711","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/AOG.0b013e31820ce18c","article-title":"Return of ovulation and menses in postpartum nonlactating women: a systematic review","volume":"117","author":"Jackson","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R68-20230711","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/AOG.0000000000000230","article-title":"Postpartum venous thromboembolism: incidence and risk factors","volume":"123","author":"Tepper","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R69-20230711","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/AOG.0b013e31820ce2db","article-title":"Risk of venous thromboembolism during the postpartum period: a systematic review","volume":"117","author":"Jackson","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R70-20230711","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1160\/TH13-09-0797","article-title":"Combined hormonal contraception and risk of venous thromboembolism within the first year following pregnancy. Danish nationwide historical cohort 1995\u20132009","volume":"112","author":"Petersen","year":"2014","journal-title":"Thromb Haemost"},{"key":"R71-20230711","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa1311485","article-title":"Risk of a thrombotic event after the 6-week postpartum period","volume":"370","author":"Kamel","year":"2014","journal-title":"N Engl J Med"},{"key":"R72-20230711","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1182\/blood-2012-11-469551","article-title":"Risk factors for first venous thromboembolism around pregnancy: a population-based cohort study from the United Kingdom","volume":"121","author":"Sultan","year":"2013","journal-title":"Blood"},{"key":"R73-20230711","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.2011.08956.x","article-title":"Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study","volume":"156","author":"Sultan","year":"2012","journal-title":"Br J Haematol"},{"key":"R74-20230711","first-page":"e251","article-title":"Long-acting reversible contraception: implants and intrauterine devices. Practice Bulletin No. 186. American College of Obstetricians and Gynecologists","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R75-20230711","first-page":"e32\u20137","article-title":"Immediate postpartum long-acting reversible contraception. Committee Opinion No. 670. American College of Obstetricians and Gynecologists","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R76-20230711","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.contraception.2015.07.009","article-title":"Immediate postpartum initiation of etonogestrel-releasing implant: a randomized controlled trial on breastfeeding impact","volume":"92","author":"Braga","year":"2015","journal-title":"Contraception"},{"key":"R79-20230711","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1097\/AOG.0000000000001318","article-title":"Optimizing support for breastfeeding as part of obstetric practice. Committee Opinion No. 658. American College of Obstetricians and Gynecologists","volume":"127","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R80-20230711","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.contraception.2015.09.010","article-title":"Progestogen-only contraceptive use among breastfeeding women: a systematic review","volume":"94","author":"Phillips","year":"2016","journal-title":"Contraception"},{"key":"R81-20230711","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.contraception.2015.05.006","article-title":"Combined hormonal contraceptive use among breastfeeding women: an updated systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"key":"R82-20230711","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/00324720701804207","article-title":"A new estimate of permanent sterility by age: sterility defined as the inability to conceive","volume":"62","author":"Leridon","year":"2008","journal-title":"Popul Stud (Camb)"},{"key":"R83-20230711","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.maturitas.2005.10.007","article-title":"Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density","volume":"54","author":"Gambacciani","year":"2006","journal-title":"Maturitas"},{"key":"R84-20230711","first-page":"913","article-title":"Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding","volume":"96","author":"Davis","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R85-20230711","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0015-0282(01)01791-5","article-title":"Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate","volume":"75","author":"Utian","year":"2001","journal-title":"Fertil Steril"},{"key":"R86-20230711","doi-asserted-by":"crossref","first-page":"580.e1","DOI":"10.1016\/j.ajog.2017.02.002","article-title":"Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study","volume":"216","author":"Iversen","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R87-20230711","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13625180008500402","article-title":"The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives","volume":"5","author":"Nightingale","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R88-20230711","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/01.AOG.0000431815.52679.bb","article-title":"Management of abnormal uterine bleeding associated with ovulatory dysfunction. Practice Bulletin No. 136. American College of Obstetricians and Gynecologists","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R89-20230711","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ajog.2015.07.044","article-title":"The medical management of abnormal uterine bleeding in reproductive-aged women","volume":"214","author":"Bradley","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R90-20230711","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.contraception.2016.10.010","article-title":"Combined hormonal contraceptive (CHC) use among obese women and contraceptive effectiveness: a systematic review","volume":"95","author":"Dragoman","year":"2017","journal-title":"Contraception"},{"key":"R92-20230711","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AOG.0b013e31828317cc","article-title":"Contraceptive failures in overweight and obese combined hormonal contraceptive users","volume":"121","author":"McNicholas","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R93-20230711","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.fertnstert.2016.07.1094","article-title":"Hormonal contraception and obesity","volume":"106","author":"Simmons","year":"2016","journal-title":"Fertil Steril"},{"key":"R94-20230711","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2009.04.011","article-title":"Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity","volume":"80","author":"Edelman","year":"2009","journal-title":"Contraception"},{"key":"R95-20230711","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.contraception.2012.10.008","article-title":"Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users","volume":"87","author":"Edelman","year":"2013","journal-title":"Contraception"},{"key":"R96-20230711","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.contraception.2014.06.033","article-title":"Correcting oral contraceptive pharmacokinetic alterations due to obesity: a randomized controlled trial","volume":"90","author":"Edelman","year":"2014","journal-title":"Contraception"},{"key":"R97-20230711","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/AOG.0b013e31820095a2","article-title":"Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen","volume":"117","author":"Dinger","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R98-20230711","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0015-0282(01)03275-7","article-title":"Contraceptive efficacy and cycle control with the Ortho Evra\/Evra transdermal system: the analysis of pooled data","volume":"77","author":"Zieman","year":"2002","journal-title":"Fertil Steril"},{"key":"R99-20230711","doi-asserted-by":"crossref","first-page":"39.e1","DOI":"10.1016\/j.ajog.2012.04.022","article-title":"Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women [published erratum appears in Am J Obstet Gynecol 2013;208:326]","volume":"207","author":"Westhoff","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R100-20230711","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0037-1613379","article-title":"Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use","volume":"89","author":"Abdollahi","year":"2003","journal-title":"Thromb Haemost"},{"key":"R101-20230711","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.contraception.2007.11.012","article-title":"Much ado about little: obesity, combined hormonal contraceptive use and venous thrombosis","volume":"77","author":"Trussell","year":"2008","journal-title":"Contraception"},{"key":"R102-20230711","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.thromres.2006.12.003","article-title":"Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study","volume":"120","author":"Larsen","year":"2007","journal-title":"Thromb Res"},{"key":"R103-20230711","doi-asserted-by":"crossref","first-page":"e96495","DOI":"10.1371\/journal.pone.0096495","article-title":"Risk factors for venous thromboembolism in 1.3 million pregnancies: a nationwide prospective cohort","volume":"9","author":"Virkus","year":"2014","journal-title":"PLoS One"},{"key":"R104-20230711","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.contraception.2016.05.014","article-title":"Combined hormonal contraceptive use among obese women and risk for cardiovascular events: a systematic review","volume":"94","author":"Horton","year":"2016","journal-title":"Contraception"},{"key":"R105-20230711","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0010-7824(77)90102-0","article-title":"Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: norethisterone oenanthate and medroxyprogesterone acetate. 1. Use-effectiveness","volume":"15","year":"1977","journal-title":"Contraception"},{"key":"R106-20230711","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2004.06.011","article-title":"Contraceptive efficacy and safety of DMPA-SC","volume":"70","author":"Jain","year":"2004","journal-title":"Contraception"},{"key":"R107-20230711","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0b013e318259565a","article-title":"Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women","volume":"120","author":"Xu","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R108-20230711","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.clinthera.2011.02.008","article-title":"Retrospective review of the relationship between weight change and demographic factors following initial depot medroxyprogesterone acetate injection in adolescents","volume":"33","author":"Gerlach","year":"2011","journal-title":"Clin Ther"},{"key":"R109-20230711","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.contraception.2009.04.006","article-title":"Progestogen-only contraceptive use in obese women","volume":"80","author":"Curtis","year":"2009","journal-title":"Contraception"},{"key":"R110-20230711","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/archpedi.160.1.40","article-title":"Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method","volume":"160","author":"Bonny","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R111-20230711","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1083-3188(01)00147-4","article-title":"Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate","volume":"15","author":"Mangan","year":"2002","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R113-20230711","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1093\/humrep\/det320","article-title":"LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study","volume":"28","author":"Gallos","year":"2013","journal-title":"Hum Reprod"},{"key":"R114-20230711","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/09513590.2012.730579","article-title":"Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women","volume":"29","author":"Morelli","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"R115-20230711","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.contraception.2010.02.008","article-title":"Contraceptive use among women with a history of bariatric surgery: a systematic review","volume":"82","author":"Paulen","year":"2010","journal-title":"Contraception"},{"key":"R116-20230711","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.contraception.2016.06.012","article-title":"Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review","volume":"94","author":"Pagano","year":"2016","journal-title":"Contraception"},{"key":"R117-20230711","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1067\/mob.2002.124939","article-title":"Safety and efficacy of fluoxetine in patients who receive oral contraceptive therapy","volume":"187","author":"Koke","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"R118-20230711","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ajog.2014.12.010","article-title":"Contraception and mental health: a commentary on the evidence and principles for practice","volume":"212","author":"Hall","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R119-20230711","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.contraception.2016.07.011","article-title":"Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review","volume":"94","author":"Berry-Bibee","year":"2016","journal-title":"Contraception"},{"key":"R120-20230711","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.contraception.2004.11.004","article-title":"Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding","volume":"71","author":"Murphy","year":"2005","journal-title":"Contraception"},{"key":"R121-20230711","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.contraception.2016.07.010","article-title":"Co-administration of St. John's wort and hormonal contraceptives: a systematic review","volume":"94","author":"Berry-Bibee","year":"2016","journal-title":"Contraception"},{"key":"R122-20230711","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/head.12279","article-title":"Headache toolbox: menstrual migraine","volume":"54","author":"Tepper","year":"2014","journal-title":"Headache"},{"key":"R124-20230711","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.contraception.2016.04.016","article-title":"Safety of hormonal contraceptives among women with migraine: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"key":"R125-20230711","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.284.1.72","article-title":"Ischemic stroke risk with oral contraceptives: a meta-analysis","volume":"284","author":"Gillum","year":"2000","journal-title":"JAMA"},{"key":"R126-20230711","doi-asserted-by":"crossref","first-page":"b3914","DOI":"10.1136\/bmj.b3914","article-title":"Migraine and cardiovascular disease: systematic review and meta-analysis","volume":"339","author":"Schurks","year":"2009","journal-title":"BMJ"},{"key":"R127-20230711","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.amjmed.2009.12.021","article-title":"Migraine headache and ischemic stroke risk: an updated meta-analysis","volume":"123","author":"Spector","year":"2010","journal-title":"Am J Med"},{"key":"R128-20230711","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.str.0000442009.06663.48","article-title":"Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council for High Blood Pressure Research","volume":"45","author":"Bushnell","year":"2014","journal-title":"Stroke"},{"key":"R129-20230711","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/bmj.38302.504063.8F","article-title":"Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies [published errata appear in BMJ 2005;330:596; BMJ 2005;330:345]","volume":"330","author":"Etminan","year":"2005","journal-title":"BMJ"},{"key":"R130-20230711","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/01.WNL.0000154528.21485.3A","article-title":"Migraine, headache, and the risk of stroke in women: a prospective study","volume":"64","author":"Kurth","year":"2005","journal-title":"Neurology"},{"key":"R131-20230711","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(96)90669-8","article-title":"History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young","volume":"347","author":"Carolei","year":"1996","journal-title":"Lancet"},{"key":"R132-20230711","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s10194-017-0815-1","article-title":"Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)","volume":"18","author":"Sacco","year":"2017","journal-title":"J Headache Pain"},{"key":"R133-20230711","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1783\/147118907781004750","article-title":"Migraine and use of combined hormonal contraceptives: a clinical review","volume":"33","author":"MacGregor","year":"2007","journal-title":"J Fam Plann Reprod Health Care"},{"key":"R134-20230711","doi-asserted-by":"crossref","first-page":"489.e1","DOI":"10.1016\/j.ajog.2016.12.019","article-title":"Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke","volume":"216","author":"Champaloux","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R135-20230711","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines [published erratum appears in J Am Coll Cardiol 2018;71:2275-9]","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R136-20230711","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.contraception.2005.08.005","article-title":"Combined oral contraceptive use among women with hypertension: a systematic review","volume":"73","author":"Curtis","year":"2006","journal-title":"Contraception"},{"key":"R137-20230711","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.contraception.2012.09.017","article-title":"Appropriate follow up to detect potential adverse events after initiation of select contraceptive methods: a systematic review","volume":"87","author":"Steenland","year":"2013","journal-title":"Contraception"},{"key":"R138-20230711","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0020-7292(97)00239-7","article-title":"Low-dose oral contraceptives and 24-hour ambulatory blood pressure","volume":"59","author":"Cardoso","year":"1997","journal-title":"Int J Gynaecol Obstet"},{"issue":"RR-4","key":"R139-20230711","first-page":"1","article-title":"U.S. selected practice recommendations for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R140-20230711","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.contraception.2003.09.002","article-title":"Progestogen-only pills and high blood pressure: is there an association? A literature review","volume":"69","author":"Hussain","year":"2004","journal-title":"Contraception"},{"key":"R141-20230711","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/2047487318774847","article-title":"Association between progestin-only contraceptive use and cardiometabolic outcomes: a systematic review and meta-analysis","volume":"25","author":"Glisic","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"R144-20230711","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1447-0756.2000.tb01195.x","article-title":"Contraception in diabetic women: comparative metabolic study of Norplant, depot medroxyprogesterone acetate, low dose oral contraceptive pill and CuT380A","volume":"26","author":"Diab","year":"2000","journal-title":"J Obstet Gynaecol Res"},{"key":"R145-20230711","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1001\/jama.284.14.1791","article-title":"Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer","volume":"284","author":"Grabrick","year":"2000","journal-title":"JAMA"},{"key":"R146-20230711","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1158\/1055-9965.EPI-06-0258","article-title":"BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. kConFab Investigators, Ontario Cancer Genetics Network Investigators","volume":"15","author":"Haile","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R147-20230711","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(01)06524-2","article-title":"Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Collaborative Group on Hormonal Factors in Breast Cancer","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"R148-20230711","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.contraception.2009.04.010","article-title":"Oral contraceptives and family history of breast cancer","volume":"80","author":"Gaffield","year":"2009","journal-title":"Contraception"},{"key":"R149-20230711","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1200\/JCO.2013.48.9021","article-title":"Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis","volume":"31","author":"Moorman","year":"2013","journal-title":"J Clin Oncol"},{"key":"R150-20230711","first-page":"dju091","article-title":"Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis [published erratum appears in J Natl Cancer Inst 2014;106:dju235]","volume":"106","author":"Friebel","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"R151-20230711","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/AOG.0b013e31824e12ce","article-title":"Management of gynecologic issues in women with breast cancer. Practice Bulletin No. 126. American College of Obstetricians and Gynecologists","volume":"119","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R152-20230711","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1102\/1470-7330.2008.0020","article-title":"The effect of tamoxifen on the genital tract","volume":"8","author":"Polin","year":"2008","journal-title":"Cancer Imaging"},{"key":"R154-20230711","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.fertnstert.2007.05.033","article-title":"Use of the levonorgestrel-releasing intrauterine system in breast cancer patients","volume":"90","author":"Trinh","year":"2008","journal-title":"Fertil Steril"},{"key":"R155-20230711","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1001\/jama.285.17.2232","article-title":"Clinical breast and pelvic examination requirements for hormonal contraception: current practice vs evidence","volume":"285","author":"Stewart","year":"2001","journal-title":"JAMA"},{"key":"R156-20230711","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J Clin Oncol"},{"key":"R157-20230711","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ajog.2015.03.037","article-title":"Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials","volume":"213","author":"Abu Hashim","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R158-20230711","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.contraception.2009.03.022","article-title":"Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic disease","volume":"80","author":"Gaffield","year":"2009","journal-title":"Contraception"},{"key":"R159-20230711","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/epi.12302","article-title":"Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry. EURAP Study Group","volume":"54","author":"Battino","year":"2013","journal-title":"Epilepsia"},{"key":"R160-20230711","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1471-0528.2011.03004.x","article-title":"Obstetric outcome in women with epilepsy: a hospital-based, retrospective study","volume":"118","author":"Borthen","year":"2011","journal-title":"BJOG"},{"key":"R161-20230711","first-page":"697","article-title":"Pregnancy, epilepsy, and women's issues","volume":"19","author":"Pennell","year":"2013","journal-title":"Continuum (Minneap Minn)"},{"key":"R162-20230711","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2010.06.013","article-title":"The use of hormonal contraception among women taking anticonvulsant therapy","volume":"83","author":"Gaffield","year":"2011","journal-title":"Contraception"},{"key":"R163-20230711","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0009-9236(95)90172-8","article-title":"Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive","volume":"58","author":"Saano","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"R164-20230711","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1528-1167.2010.02917.x","article-title":"Carbamazepine coadministration with an oral contraceptive: effects on steroid pharmacokinetics, ovulation, and bleeding","volume":"52","author":"Davis","year":"2011","journal-title":"Epilepsia"},{"key":"R165-20230711","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1365-2125.1990.tb05457.x","article-title":"The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids","volume":"30","author":"Crawford","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"R166-20230711","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1528-1157.1997.tb01123.x","article-title":"Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy","volume":"38","author":"Rosenfeld","year":"1997","journal-title":"Epilepsia"},{"key":"R167-20230711","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1528-1157.1999.tb00779.x","article-title":"Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women","volume":"40","author":"Fattore","year":"1999","journal-title":"Epilepsia"},{"key":"R169-20230711","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1783\/147118902101195992","article-title":"Observational series on women using the contraceptive Mirena concurrently with anti-epileptic and other enzyme-inducing drugs","volume":"28","author":"Bounds","year":"2002","journal-title":"J Fam Plann Reprod Health Care"},{"key":"R170-20230711","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.contraception.2017.03.004","article-title":"The effect of carbamazepine on etonogestrel concentrations in contraceptive implant users","volume":"95","author":"Lazorwitz","year":"2017","journal-title":"Contraception"},{"key":"R171-20230711","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00404-005-0064-4","article-title":"Failure of Implanon contraception in a patient taking carbamazepin for epilepsia","volume":"273","author":"Schindlbeck","year":"2006","journal-title":"Arch Gynecol Obstet"},{"key":"R172-20230711","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1752-1947-8-43","article-title":"Decreased efficacy of an etonogestrel implant in a woman on antiepileptic medications: a case report","volume":"8","author":"Lange","year":"2014","journal-title":"J Med Case Rep"},{"key":"R173-20230711","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/j.1528-1167.2005.10105.x","article-title":"Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations","volume":"46","author":"Reimers","year":"2005","journal-title":"Epilepsia"},{"key":"R174-20230711","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1528-1167.2007.00997.x","article-title":"Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial","volume":"48","author":"Christensen","year":"2007","journal-title":"Epilepsia"},{"key":"R175-20230711","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00563105","article-title":"The effect of rifampicin on norethisterone pharmacokinetics","volume":"15","author":"Back","year":"1979","journal-title":"Eur J Clin Pharmacol"},{"key":"R176-20230711","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0010-7824(80)90125-0","article-title":"The effect of rifampicin on the pharmacokinetics of ethynylestradiol in women","volume":"21","author":"Back","year":"1980","journal-title":"Contraception"},{"key":"R177-20230711","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/009127009803801109","article-title":"Effects of rifabutin and rifampicin on the pharmacokinetics of ethinylestradiol and norethindrone","volume":"38","author":"LeBel","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"R178-20230711","first-page":"853","article-title":"Drug interactions between oral contraceptives and antibiotics. Council on Scientific Affairs, American Medical Association","volume":"98","author":"Dickinson","year":"2001","journal-title":"Obstet Gynecol"},{"key":"R179-20230711","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1067\/mjd.2002.120448","article-title":"Oral contraceptive efficacy and antibiotic interaction: a myth debunked","volume":"46","author":"Archer","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R180-20230711","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajog.2017.07.003","article-title":"Drug interactions between non-rifamycin antibiotics and hormonal contraception: a systematic review","volume":"218","author":"Simmons","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R181-20230711","first-page":"218","article-title":"Evaluation of interaction between fluconazole and an oral contraceptive in healthy women","volume":"98","author":"Hilbert","year":"2001","journal-title":"Obstet Gynecol"},{"key":"R182-20230711","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.contraception.2003.10.001","article-title":"The contraceptive vaginal ring, NuvaRing, and antimycotic co-medication","volume":"69","author":"Verhoeven","year":"2004","journal-title":"Contraception"},{"key":"R183-20230711","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-200544040-00007","article-title":"Absence of pharmacokinetic interactions of the combined contraceptive vaginal ring NuvaRing with oral amoxicillin or doxycycline in two randomised trials","volume":"44","author":"Dogterom","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"R184-20230711","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0015-0282(01)03261-7","article-title":"Pharmacokinetic overview of Ortho Evra\/Evra","volume":"77","author":"Abrams","year":"2002","journal-title":"Fertil Steril"},{"key":"R186-20230711","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.contraception.2009.04.008","article-title":"Use of contraceptive methods by women with current venous thrombosis on anticoagulant therapy: a systematic review","volume":"80","author":"Culwell","year":"2009","journal-title":"Contraception"},{"key":"R187-20230711","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/13625180400020952","article-title":"Depot-medroxyprogesterone acetate in anticoagulated patients with previous hemorrhagic corpus luteum","volume":"10","author":"Sonmezer","year":"2005","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R188-20230711","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.ajog.2005.05.002","article-title":"The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders","volume":"193","author":"Schaedel","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R189-20230711","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1177\/0961203306071706","article-title":"Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil)","volume":"15","author":"Pisoni","year":"2006","journal-title":"Lupus"},{"key":"R190-20230711","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/AOG.0b013e3182118ac3","article-title":"Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial","volume":"117","author":"Jensen","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R191-20230711","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-201902000-00041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:02:38Z","timestamp":1795024958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-201902000-00041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":178,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003072","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}